Health Care & Life Sciences » Pharmaceuticals | Crescita Therapeutics Inc.

Crescita Therapeutics Inc. | Cash Flow

Fiscal year is January-December. All values CAD Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
14,601.00
7,465.00
14,638.00
11,258.00
2,422
Depreciation, Depletion & Amortization
300.00
37.00
418.00
1,161.00
1,146
Other Funds
9,105.00
13,941.00
39,537.00
-
319
Funds from Operations
12,889.00
15,083.00
15,186.00
4,992.00
1,476
Changes in Working Capital
3,591.00
1,165.00
3,391.00
2,410.00
2,954
Net Operating Cash Flow
9,298.00
13,918.00
18,577.00
7,402.00
1,478
Capital Expenditures
43.00
23.00
123.00
107.00
Purchase/Sale of Investments
-
-
8,551.00
8,551.00
Net Investing Cash Flow
43.00
23.00
11,418.00
7,744.00
Issuance/Reduction of Debt, Net
-
-
-
3,184.00
Net Financing Cash Flow
9,105.00
13,941.00
39,582.00
3,159.00
Net Change in Cash
178.00
35.00
9,329.00
2,810.00
Free Cash Flow
9,341.00
13,941.00
18,700.00
7,509.00
Net Assets from Acquisitions
-
-
2,744.00
700.00
Change in Capital Stock
-
-
45.00
25.00
Exchange Rate Effect
58.00
35.00
258.00
7.00

About Crescita Therapeutics

View Profile
Address
2805 Place Louis-R Renaud
Laval Québec H7V 0A3
Canada
Employees -
Website http://www.crescitatherapeutics.com
Updated 07/08/2019
Crescita Therapeutics, Inc. is a dermatology company, which engages in the provisio of non-prescription skincare products and prescription drug products for the treatment and care of skin conditions and diseases. It operates tgrough the following geographical segments: Canada, United States, Europe, and Other Foreign Countries. The company was founded in 2016 and is headquartered in Mississauga, Canada.